Industry Trends

Bemis vs. Berry Global for Healthcare Packaging: A Quality Manager's Comparison

Bemis vs. Berry Global for Healthcare Packaging: A Quality Manager's Comparison

I've been reviewing healthcare packaging specifications for about six years now—roughly 180 to 200 unique SKUs annually across pharmaceutical and medical device lines. In 2023, I rejected 12% of first deliveries due to barrier performance failures or documentation gaps. That number dropped to 7% in 2024 after we restructured our vendor evaluation process.

The question I get most often from procurement: "Bemis or Berry Global for our medical packaging?" And honestly, the answer depends on what's going to keep you up at night. (Should mention: when I say Bemis, I'm referring to what's now part of Amcor since the 2019 acquisition—the flexible packaging and healthcare packaging division, not Bemis Manufacturing which makes sharps containers and toilet seats.)

What We're Actually Comparing

I'm going to break this down across four dimensions that matter for healthcare packaging decisions:

• Barrier technology and film performance
• Regulatory documentation support
• Supply chain reliability
• Total cost of ownership (not just unit price)

Quick disclosure: we've worked with both suppliers over the past four years. I'm not here to tell you one is universally better. I'm here to help you figure out which one fits your situation.

Barrier Technology: Where the Real Differences Show

Bemis (Amcor)

Bemis built its reputation on barrier films before the acquisition, and Amcor has maintained that focus. Their healthcare-grade barrier films consistently hit oxygen transmission rates (OTR) below 0.5 cc/m²/day in our testing—sometimes way below. For moisture-sensitive pharmaceuticals, this matters.

We ran qualification testing on their high-barrier pouches in Q2 2024. Delta E on printed surfaces stayed under 2 across a 50,000-unit run. Color consistency was, honestly, better than I expected for flexible packaging.

Berry Global

Berry's strength is breadth. They offer a wider range of film structures at various price points. Their standard healthcare films typically come in at OTR of 1.0-1.5 cc/m²/day—perfectly acceptable for many applications, just not ultra-sensitive ones.

The most frustrating part of working with Berry on specialty barriers: the same films performing differently across manufacturing sites. You'd think a specification would mean the same thing everywhere, but interpretation varies. We've learned to specify the manufacturing location in contracts.

The Verdict on Barrier Performance

If you're packaging anything where barrier failure means product degradation or shortened shelf life, Bemis/Amcor has the edge. At least, that's been my experience with pharmaceutical applications. For standard medical device packaging where you need sterile barrier but not extreme moisture/oxygen protection, Berry's mid-tier options work fine—and cost maybe 15-20% less.

Regulatory Documentation: The Hidden Time Sink

Bemis (Amcor)

Here's where the Amcor acquisition actually helps. Their documentation packages for FDA submissions are comprehensive. When we needed extractables and leachables data for a 510(k) submission in 2023, they provided it within three weeks. (I really should document this process for our team—we've relied on institutional knowledge too long.)

They maintain Drug Master Files (DMFs) for their healthcare packaging materials. If you're working with pharmaceutical companies, this saves a ton of time on regulatory submissions.

Berry Global

Berry's documentation is adequate but requires more back-and-forth. After the third request for supplementary testing data on the same product line, I was ready to build it into our project timelines. What finally helped was establishing a dedicated technical contact—not just using the sales rep as a go-between.

They're improving, though. Their 2024 documentation packages were noticeably more complete than what we got in 2022.

The Verdict on Regulatory Support

For pharmaceutical packaging requiring FDA submission support, Bemis/Amcor reduces your regulatory burden. For Class I and most Class II medical devices, Berry's documentation is sufficient—you'll just need to budget an extra 2-3 weeks for follow-up requests.

Supply Chain Reliability: The 2024 Reality

I didn't fully understand the value of supplier network depth until a resin shortage in late 2023 delayed three of our product launches.

Bemis (Amcor)

The Amcor global network is real. When our primary manufacturing site had capacity issues, they shifted production to another facility with minimal qualification headaches. Lead times in 2024 averaged 4-5 weeks for standard items, 6-8 for custom structures.

One caveat: their minimum order quantities are higher. We're talking 50,000 units for custom pouches versus Berry's 25,000 minimum. For a $18,000 project with specialized requirements, that matters.

Berry Global

Berry's North American footprint is extensive, which helps with regional supply chain disruptions. Lead times ran similar to Amcor—around 4-6 weeks standard.

Where they struggled: communication during delays. We had a batch running three weeks late in February 2024, and getting accurate updates required multiple calls. The eventual delivery was fine, but the uncertainty cost us internally.

The Verdict on Supply Chain

For global operations or companies with international regulatory needs, Amcor's network gives you flexibility. For US-focused operations with moderate volumes, Berry's lower MOQs might matter more than global reach.

Total Cost of Ownership: Beyond the Quote

Everyone told me to look past unit price. I only believed it after ignoring it once and eating a $4,200 mistake on a Berry order where we hadn't specified testing requirements clearly enough. The "cheaper" quote ended up costing 18% more than the "expensive" Bemis option once we factored in requalification.

Price Comparison (Based on our 2024 orders)

For comparable high-barrier healthcare pouches, Bemis/Amcor ran about $0.08-0.12 per unit higher than Berry's equivalent. On a 100,000-unit annual order, that's $8,000-12,000 difference.

But then again—we had zero quality rejections on Amcor material in 2024 versus three batches requiring rework from Berry. Those reworks cost us roughly $6,500 in labor and expedited shipping.

Hidden Cost Factors

• Documentation costs: Amcor includes more regulatory documentation in standard pricing. Berry charges $500-1,500 for supplementary testing data packages.
• Sample fees: Both charge for custom samples—typically $200-400 for initial rounds. Amcor waives sample fees on orders over $25,000.
• Tooling: Custom pouch tooling runs $800-2,000 at either supplier. Die cutting setup adds $50-200 depending on complexity.

The Verdict on Cost

If your quality team is stretched thin and rejection rework is expensive, the Amcor premium might pay for itself. If you have robust incoming inspection and can catch issues early, Berry's lower unit cost makes sense. (Note to self: we should actually calculate our cost-per-rejection to make this comparison more precise.)

When to Choose Bemis/Amcor

I recommend Amcor's healthcare packaging for these situations:

• Pharmaceutical applications requiring DMF support
• Products with moisture sensitivity requiring OTR below 1.0 cc/m²/day
• Companies with limited regulatory/quality staff who need turnkey documentation
• Global operations needing manufacturing flexibility across regions
• Annual volumes exceeding 100,000 units (where their MOQs aren't a constraint)

When to Choose Berry Global

Berry makes more sense when:

• Standard barrier requirements are sufficient for your application
• You need lower MOQs (under 50,000 units)
• Your team can handle supplementary documentation requests
• Price sensitivity is high and your QC process can catch variability early
• You're primarily US-focused and don't need global manufacturing options

What I'd Do Differently

The vendor failure in March 2023 changed how I think about single-sourcing healthcare packaging. One critical deadline missed because of capacity issues, and suddenly qualification costs for a backup supplier didn't seem like overkill.

If I were setting up a healthcare packaging supply chain today, I'd qualify both—Amcor for critical barrier applications and Berry for standard items. The qualification cost (maybe $15,000-20,000 total, give or take) is insurance against the $40,000+ cost of a product launch delay.

Neither supplier is perfect. They're reliable for 90% of situations. The question is whether your products fall into the other 10%—and whether you've built enough buffer into your timelines to handle the occasional issue.

Reference: Industry standard color tolerance for printed packaging is Delta E < 2 for brand-critical colors. Delta E of 2-4 is noticeable to trained observers; above 4 is visible to most people. (Pantone Color Matching System guidelines)